$100M sweet spot round size
Most of their 5 investments are in rounds between $65M and $150M
2010
Krystal Biotech, Inc. raised $160M on May 21, 2023
Investors: Redmile Group, Braidwell and Avoro Capital Advisors (formerly venBio Select Advisor)
Kymera Therapeutics raised $150M on August 19, 2022
Investors: T. Rowe Price, Redmile Group and Avoro Capital Advisors (formerly venBio Select Advisor)
Scribe Therapeutics raised $100M on March 31, 2021
Investors: Wellington Management, RA Capital Management, L.P., T. Rowe Price, Andreessen Horowitz, Perceptive Advisors, OrbiMed Advisors, Menlo Ventures and Avoro Capital Advisors (formerly venBio Select Advisor)
PMV Pharmaceuticals, Inc. raised $70M on August 3, 2020
Investors: Nextech Invest, OrbiMed Advisors, Viking Global Investors, RA Capital Management, L.P., Wellington Management and Avoro Capital Advisors (formerly venBio Select Advisor)
Mersana Therapeutics raised $65M on April 7, 2020
Investors: Consonance Capital and Avoro Capital Advisors (formerly venBio Select Advisor)